MISSISSAUGA, ONTARIO -- (MARKET WIRE) -- September 07, 2006 -- BioSyent Inc. (“BioSyent”) (TSX VENTURE: RX) today updated shareholders on sales progress for the first eight months of the fiscal year. Product sales for the eight months ending August 31, 2006 were $850,289, an increase of $388,034 over the same eight month period in 2005. The 84% increase in sales for the first eight months of 2006 has been driven primarily by strong demand for Protect-It® in Canada.
